298 related articles for article (PubMed ID: 35836877)
1. Advances in the clinical development of oncolytic viruses.
Li K; Zhao Y; Hu X; Jiao J; Wang W; Yao H
Am J Transl Res; 2022; 14(6):4192-4206. PubMed ID: 35836877
[TBL] [Abstract][Full Text] [Related]
2. Fighting Cancer with Viruses: Oncolytic Virus Therapy in China.
Wei D; Xu J; Liu XY; Chen ZN; Bian H
Hum Gene Ther; 2018 Feb; 29(2):151-159. PubMed ID: 29284308
[TBL] [Abstract][Full Text] [Related]
3. Oncolytic viruses: challenges and considerations in an evolving clinical landscape.
Lauer UM; Beil J
Future Oncol; 2022 Jul; ():. PubMed ID: 35818970
[TBL] [Abstract][Full Text] [Related]
4. Research Advances of Clinical Application of Oncolytic Viruses in Treatment of Gynecologic Cancers.
Deng M; Wang Q
Curr Cancer Drug Targets; 2023; 23(7):505-523. PubMed ID: 36824004
[TBL] [Abstract][Full Text] [Related]
5. Review: Oncolytic virotherapy, updates and future directions.
Fountzilas C; Patel S; Mahalingam D
Oncotarget; 2017 Nov; 8(60):102617-102639. PubMed ID: 29254276
[TBL] [Abstract][Full Text] [Related]
6. Oncolytic viruses in lung cancer treatment: a review article.
Sakhi H; Arabi M; Ghaemi A; Movafagh A; Sheikhpour M
Immunotherapy; 2024 Feb; 16(2):75-97. PubMed ID: 38112057
[TBL] [Abstract][Full Text] [Related]
7. Immune System, Friend or Foe of Oncolytic Virotherapy?
Filley AC; Dey M
Front Oncol; 2017; 7():106. PubMed ID: 28589085
[TBL] [Abstract][Full Text] [Related]
8. Oncolytic virotherapy as promising immunotherapy against cancer: mechanisms of resistance to oncolytic viruses.
Goradel NH; Alizadeh A; Hosseinzadeh S; Taghipour M; Ghesmati Z; Arashkia A; Negahdari B
Future Oncol; 2022 Jan; 18(2):245-259. PubMed ID: 34821517
[TBL] [Abstract][Full Text] [Related]
9. The Current Status and Future Prospects of Oncolytic Viruses in Clinical Trials against Melanoma, Glioma, Pancreatic, and Breast Cancers.
Eissa IR; Bustos-Villalobos I; Ichinose T; Matsumura S; Naoe Y; Miyajima N; Morimoto D; Mukoyama N; Zhiwen W; Tanaka M; Hasegawa H; Sumigama S; Aleksic B; Kodera Y; Kasuya H
Cancers (Basel); 2018 Sep; 10(10):. PubMed ID: 30261620
[TBL] [Abstract][Full Text] [Related]
10. History of how viruses can fight cancer: From the miraculous healings to the approval of oncolytic viruses.
Bifulco M; Di Zazzo E; Napolitano F; Malfitano AM; Portella G
Biochimie; 2023 Mar; 206():89-92. PubMed ID: 36273765
[TBL] [Abstract][Full Text] [Related]
11. Oncolytic Viruses in Cancer Treatment: A Review.
Lawler SE; Speranza MC; Cho CF; Chiocca EA
JAMA Oncol; 2017 Jun; 3(6):841-849. PubMed ID: 27441411
[TBL] [Abstract][Full Text] [Related]
12. The efficacy and safety of oncolytic viruses in the treatment of intermediate to advanced solid tumors: a systematic review and meta-analysis.
Gao P; Ding G; Wang L
Transl Cancer Res; 2021 Oct; 10(10):4290-4302. PubMed ID: 35116288
[TBL] [Abstract][Full Text] [Related]
13. Clinical Advances and Future Directions of Oncolytic Virotherapy for Head and Neck Cancer.
Wang Z; Sun P; Li Z; Xiao S
Cancers (Basel); 2023 Nov; 15(21):. PubMed ID: 37958464
[TBL] [Abstract][Full Text] [Related]
14. Oncolytic viruses and their application to cancer immunotherapy.
Chiocca EA; Rabkin SD
Cancer Immunol Res; 2014 Apr; 2(4):295-300. PubMed ID: 24764576
[TBL] [Abstract][Full Text] [Related]
15. Perspectives on immunotherapy via oncolytic viruses.
Reale A; Vitiello A; Conciatori V; Parolin C; Calistri A; Palù G
Infect Agent Cancer; 2019; 14():5. PubMed ID: 30792754
[TBL] [Abstract][Full Text] [Related]
16. Biomarker screen for efficacy of oncolytic virotherapy in patient-derived pancreatic cancer cultures.
Schäfer TE; Knol LI; Haas FV; Hartley A; Pernickel SCS; Jády A; Finkbeiner MSC; Achberger J; Arelaki S; Modic Ž; Schröer K; Zhang W; Schmidt B; Schuster P; Haferkamp S; Doerner J; Gebauer F; Ackermann M; Kvasnicka HM; Kulkarni A; Bots STF; Kemp V; Hawinkels LJAC; Poetsch AR; Hoeben RC; Ehrhardt A; Marchini A; Ungerechts G; Ball CR; Engeland CE
EBioMedicine; 2024 Jun; 105():105219. PubMed ID: 38941955
[TBL] [Abstract][Full Text] [Related]
17. Past, Present and Future of Oncolytic Reovirus.
Müller L; Berkeley R; Barr T; Ilett E; Errington-Mais F
Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33142841
[TBL] [Abstract][Full Text] [Related]
18. The discovery and development of oncolytic viruses: are they the future of cancer immunotherapy?
Zhang S; Rabkin SD
Expert Opin Drug Discov; 2021 Apr; 16(4):391-410. PubMed ID: 33232188
[No Abstract] [Full Text] [Related]
19. Clinical landscape of oncolytic virus research in 2020.
Macedo N; Miller DM; Haq R; Kaufman HL
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33046622
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy by mesenchymal stromal cell delivery of oncolytic viruses for treating metastatic tumors.
Yoon AR; Rivera-Cruz C; Gimble JM; Yun CO; Figueiredo ML
Mol Ther Oncolytics; 2022 Jun; 25():78-97. PubMed ID: 35434272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
